Dais Signs Agreement with Leading Provider of Advanced Solutions for Contaminated Water Treatment in China
Dais Signs Agreement with Leading Provider of Advanced Solutions for Contaminated Water Treatment in China.
ODESSA, FL–(Marketwired – Apr 25, 2017) – Dais Analytic Corporation ( OTCQB : DLYT ), a commercial nanotechnology materials business selling its industry-changing nanomaterial technology into the worldwide water, air and energy markets, announced today that it has entered into a three-year Cooperation Agreement with Beijing Geoenviron Engineering and Technology, Inc. (603588.SS), a leader in providing advanced pollution prevention and treatment solutions in Mainland China, to distribute Dais’ NanoClear™ products for the treatment of aggressively contaminated industrial wastewater.
BGE will purchase membrane evaporators from Dais and design, procure and buildout the balance of the water pollution treatment systems with Dais providing guidance and support for NanoClear portion of the system.
Mr. Tangredi went on to say, "Entering into this Cooperation Agreement with BGE is a significant milestone for our Company.
About Dais Analytic Corporation Dais Analytic Corporation (OTCQB: DLYT) is a nanotechnology business producing a versatile family of membrane materials — called Aqualyte — focusing on evolutionary or disruptive air, energy and water applications.
To find out more about Dais please visit www.daisanalytic.com About Beijing Geoenviron Engineering and Technology, Inc. Beijing Geoenviron Engineering and Technology, Inc., a Shanghai Stock Exchange listed company (603588.SS) is a leader in providing advanced technology integrated solid waste management solutions.
Founded in 1992, BGE was spun out of the Chinese Academy of Sciences Institute of High Energy Physics Lining Engineering Division and employs a staff of over 750 people.
Statements that are not historical facts, including statements about the Company’s beliefs and expectations, are forward-looking statements.
Forward-looking statements involve inherent risks and uncertainties that could cause actual results to differ materially from the forward-looking statements.
For example, statements about future revenues and the Company’s ability to fund its operations and contractual obligations are forward looking and subject to risks.